Trial Profile
A trial to identify the genetic changes that are associated with sunitinib clinical response in patient with advanced renal cell carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2016
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Pharmacodynamics
- 11 Aug 2016 New trial record